Severe Opioid Withdrawal Due to Misuse of New Combined Morphine and Naltrexone Product (Embeda)

Annals of Emergency Medicine

Volumn 55, Issue 3, 2010, Pages 303-304

  Jang, David H ^a   Rohe, John C ^b   Hoffman, Robert S ^a   Nelson, Lewis S ^a  

^a NEW YORK UNIVERSITY   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; MORPHINE; NALTREXONE;

ADULT; CHRONIC PAIN; CLINICAL ARTICLE; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; NAUSEA; PAIN; PRIORITY JOURNAL; VOMITING;

ADULT; DRUG COMBINATIONS; FEMALE; HUMANS; MORPHINE; NALTREXONE; PATIENT EDUCATION AS TOPIC; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 76549093421     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2009.10.013     Document Type: Letter

References (2)

1. Embeda drug insert. http://www.embeda.com Accessed October 10, 2009
2. Nelson L.S. Opioids. In: Flomenbaum N.E., Goldfrank L.R., Hoffman R.S., and e.a. (Eds). Goldfrank's Toxicologic Emergencies. 8th ed. (2006), McGraw-Hill, New York, NY 590-613